Re: OB-GYN-L digest 4898
From: Garry E. Siegel, M.D. (garrys@mindspring.com)
Fri May 26 21:26:23 2006
Thanks; the ACOG update tape alluded to the same program.
Garry
At Fri, 26 May 2006, ATB28@aol.com wrote:
>
>Garry,
>
>This is being offered in several parts of the country, with services
>coordinated through the lab. The labs that participate incorporate NT results if
>provided to them from sonographers/docs who participate in
>Fetal-Medicine-Foundation, NTQR, or other ongoing Quality Assessment programs.
>
>I agree, demonstration of consistency of NT examination as well as
>participation in ongoing quality assessment programs - much like labs do with outside
>CAP assessment of their biochemical analyses - is essential.
>
>The process is in evolution and will, we all hope, continue to improve.
>There may well be regional variations on the specific model used, but qc is
>essential.
>
>Allan T Bombard, MD
>Chief Medical Officer
>Sharp Mary Birch Hospital for Women
>3003 Health Center Drive
>San Diego, CA 92123
>
>In a message dated 5/26/2006 5:34:45 A.M. Pacific Daylight Time,
>ob-gyn-l@obgyn.net writes:
>
>----------------------------------------------------------------------
>
>----------------------------------------------------------------------
>Date: Thu, 25 May 2006 19:27:01 -0500 (CDT)
>----------------------------------------------------------------------
>----------------------------------------------------------------------
>From: garrys@mindspring.com (Garry E. Siegel, M.D.)
>----------------------------------------------------------------------
>
>--
>----------------------------------------------------------------------
>To: OB-GYN-L@OBGYN.net
>----------------------------------------------------------------------
>Subject: Re: FASTER trial/clinical practice
>----------------------------------------------------------------------
>Message-ID: <200605260027.k4Q0R1E12846@dns.obgyn.net>
>
>FWIW, a recent ACOG update tape was very good on the subject. The
>moderator, Mary D'Alton, summarized that Down Syndrome screening in the
>US is in transition. The implication is that some form of integrated or
>sequential screening (there are several different combos of how you link
>first trimester analytes, nuchal translucency, and second trimester
>analytes--separate, integrated, sequential, contingent, etc.) will
>likely be the norm in the future, but the logistics have to get up to
>speed, i.e. the mass of sonographers have to get up to speed on nuchal
>translucency.
>
>She also said that ongoing quality control is paramount, and not to
>simply start doing this on your own.
>
>Garry
>
>At Thu, 25 May 2006, Marie Harkins wrote:
>>
>>I was wondering what folks are offering women in the way of non
>>invasive screening for Down Syndrome?
>>
>>Is anyone routinely offering step-wise sequential screening (first and
>>second trimester screens) or serum integrated screening without nuchal
>>translucency? If so, are you offering it to all women regardless of
>>age and risk factors?
>>
>>Our practice is working on ways to increase the consistency of our
>>counseling in this area, but even our various consulting
>>perinatologists seem to be doing things differently.
>>
>>I am curious about what is going on in other places and would love some
>>input from this diverse crowd.
>>
>>--
>>Marie Harkins, CNM
>>Ithaca, NY
>>
>--
>Garry E. Siegel, M.D.
>Private Practice
>Roswell, GA
>
--
Garry E. Siegel, M.D.
Private Practice
Roswell, GA
|
|
